Model Number: G-20.''
Brand Name: Great-Ears
Key Specifications/Special Features:
Behind-the-ear (BTE) hearing aids are used for all types of hearing losses from mild to profound.The G-20, BTE a hearing aid is consists of a case, an ear mold or dome and a connection between them. The case contains the electronics, controls, battery, microphone(s) and often the loudspeaker.Model: G-20+BTE hearing aid+Unique behind the ear design+ Adjustable volume button+ Power on/off switcher+Analog, digital hearing aids, rechargeable hearing aid, ear hearing amplifier, ITE, CTC models availableBTE hearing aids has brand name of great-ears
1. Factory locates in Zhongshan City of Guangdong Province
2. International business Office is located in Shenzhen city of Guangdong ProvinceTips: hearing aids styles: Hearing aids have been available in four styles: body, eyeglass, behind-the-ear (BTE), in-the-ear (ITE)
Included in the category of ITE hearing aids are in-the-canal (ITC) and completely-in-the-canal (CIC) styles (all shown in the figures below)
While body and eyeglass style hearing aids were regularly used 40-50 years ago, they comprise only about 1% of all hearing aids marketed today
Instead, most individuals choose ITE (approximately 80%) or BTE (approximately 20%) style hearing aids
This transition in style, use, preference is occurring for a number of reasons, including the reduction in the size of the components, durability, cosmetic concerns on the part of the consumer
Product |
Portable behind the ear adjustable BTE hearing aid |
Technical Data |
IEC 60118-7/ANSI S3.22-2003 |
Model |
G-20 |
Peak OSPL 90 (dB SPL) |
135dB |
HAF OSPL 90 (dB SPL) |
126dB |
Sound Gain |
≥50dB |
Total harmonic wave distortion |
≤5% |
Frequency range |
300Hz-4000Hz |
Input Noise |
≤40dB |
Zinc Air battery |
AG13 or A675 |
Power consumption |
DC 1.5V, Current: ≤4mA |
Power switcher |
Yes, on/off button |
Battery working |
Working day time 10-20 days |
Package |
Color box: 3.5*8.5*12cm/unit, Gross weight:85g/unit |
Certificates Approved |
CE,FCC & RoHS, and the FDA 2017 |